Case number 1:23-cv-00550
Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 5, 2023 | 7 | STIPULATION and [Proposed] Order Regarding Service of Complaint and Case Consolidation by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 06/05/2023) (4) |
| May 19, 2023 | 1 | Complaint* (1) |
| May 19, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 05/19/2023) (3) |
| May 19, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/07/2023. Date of Expiration of Patent: See Attached. (vfm) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,962,630 ;9,416,136. (vfm) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Corporate Parent Otsuka Pharmaceutical Co., Ltd., Corporate Parent Otsuka Holdings Co., Ltd. for Astex Therapeutics Ltd. filed by Astex Therapeutics Ltd.. (vfm) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (vfm) (Entered: 05/19/2023) (2) |
